Home/Filings/4/0000899243-21-014967
4//SEC Filing

Ros Matthew 4

Accession 0000899243-21-014967

CIK 0001622229other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 9:06 PM ET

Size

5.9 KB

Accession

0000899243-21-014967

Insider Transaction Report

Form 4
Period: 2021-04-01
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-04-01$5.66/sh+2,068$11,6962,068 total
    Exercise: $9.08Exp: 2031-04-01Common Stock (2,068 underlying)
Footnotes (2)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
  • [F2]This option is fully vested at time of grant.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001673802

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:06 PM ET
Size
5.9 KB